LACTOSEPharmaceuticals
Lactose India Ltd — Cash Flow Statement
₹80.41
-7.75%
Lactose India Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Free Cash Flow | -14.67 Cr | 6.56 Cr | 6.33 Cr | 7.14 Cr | — |
| Issuance Of Capital Stock | 6.53 Cr | 0.00 | 0.00 | 1.81 Cr | — |
| Capital Expenditure | -14.38 Cr | -2.19 Cr | -1.56 Cr | -1.32 Cr | — |
| End Cash Position | 4.48 Cr | 1.53 Cr | 0.58 Cr | 1.92 Cr | — |
| Beginning Cash Position | 1.53 Cr | 0.58 Cr | 1.92 Cr | 2.16 Cr | — |
| Changes In Cash | 2.95 Cr | 0.95 Cr | -1.34 Cr | -0.24 Cr | — |
| Financing Cash Flow | 18.81 Cr | -5.72 Cr | -8.32 Cr | -8.14 Cr | — |
| Interest Paid Cff | -5.29 Cr | -5.18 Cr | -5.97 Cr | -5.12 Cr | — |
| Net Common Stock Issuance | 6.53 Cr | 0.00 | 0.00 | 1.81 Cr | — |
| Common Stock Issuance | 6.53 Cr | 0.00 | 0.00 | 1.81 Cr | — |
| Net Issuance Payments Of Debt | 18.12 Cr | -0.30 Cr | -2.11 Cr | -4.64 Cr | — |
| Net Long Term Debt Issuance | 18.12 Cr | -0.30 Cr | -1.33 Cr | -3.25 Cr | — |
| Investing Cash Flow | -15.57 Cr | -2.08 Cr | -0.92 Cr | -0.56 Cr | — |
| Interest Received Cfi | 0.08 Cr | 0.08 Cr | 0.04 Cr | 0.15 Cr | — |
| Net Investment Purchase And Sale | -0.13 Cr | 84000.00 | 0.56 Cr | 0.32 Cr | — |
| Net PPE Purchase And Sale | -13.92 Cr | -2.16 Cr | -1.51 Cr | -1.03 Cr | — |
| Sale Of PPE | 0.46 Cr | 0.02 Cr | 0.05 Cr | 0.29 Cr | — |
| Purchase Of PPE | -14.38 Cr | -2.19 Cr | -1.56 Cr | -1.32 Cr | — |
| Operating Cash Flow | -0.29 Cr | 8.75 Cr | 7.89 Cr | 8.47 Cr | — |
| Taxes Refund Paid | -1.13 Cr | -0.77 Cr | -0.04 Cr | 0.07 Cr | — |
| Change In Working Capital | -16.42 Cr | -10.08 Cr | -4.13 Cr | -4.36 Cr | — |
| Change In Other Current Liabilities | 0.22 Cr | -0.38 Cr | -1.16 Cr | 0.29 Cr | — |
| Change In Other Current Assets | -3.26 Cr | -2.00 Cr | 0.87 Cr | -3.09 Cr | — |
| Change In Payable | 2.34 Cr | -9.92 Cr | 13.80 Cr | 1.87 Cr | — |
| Change In Prepaid Assets | -2.17 Cr | -1.29 Cr | -0.81 Cr | — | — |
| Change In Inventory | -7.76 Cr | 5.99 Cr | -15.66 Cr | 1.20 Cr | — |
| Change In Receivables | -6.16 Cr | -2.84 Cr | -1.22 Cr | -4.88 Cr | — |
| Other Non Cash Items | 5.13 Cr | 5.13 Cr | 5.91 Cr | 4.97 Cr | — |
| Provisionand Write Offof Assets | -0.09 Cr | -0.03 Cr | 0.08 Cr | -0.03 Cr | — |
| Depreciation And Amortization | 5.39 Cr | 5.22 Cr | 4.69 Cr | 4.56 Cr | — |
| Depreciation | 5.39 Cr | 5.22 Cr | 4.69 Cr | 4.56 Cr | — |
| Pension And Employee Benefit Expense | -0.06 Cr | -0.34 Cr | 0.09 Cr | -0.09 Cr | — |
| Net Foreign Currency Exchange Gain Loss | 4000.00 | -0.04 Cr | -0.14 Cr | -76000.00 | — |
| Gain Loss On Sale Of PPE | -0.03 Cr | -0.01 Cr | -0.03 Cr | 0.24 Cr | — |
| Net Income From Continuing Operations | 6.92 Cr | 9.66 Cr | 1.46 Cr | 3.17 Cr | — |
| Other Cash Adjustment Outside Changein Cash | — | -1000.00 | -1000.00 | — | -1000.00 |
| Net Other Financing Charges | — | 0.34 Cr | 1000.00 | — | -1000.00 |
| Net Short Term Debt Issuance | — | 6.27 Cr | -0.78 Cr | -1.39 Cr | 1.16 Cr |
| Net Other Investing Changes | — | -1000.00 | — | -2000.00 | 1000.00 |
| Gain Loss On Investment Securities | — | 1000.00 | 1000.00 | -0.04 Cr | -88000.00 |
| Sale Of Investment | — | — | — | 0.35 Cr | — |
| Purchase Of Investment | — | — | — | -0.02 Cr | -0.87 Cr |
| Capital Expenditure Reported | — | — | — | 0.00 | 0.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Lactose India Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.